Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1198)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2971)
  2. Department of Medicine (2971)
  3. Hematologic Malignancies, Division of (2848)
  4. Survivorship Research (1389)
  5. GSK Faculty (931)
  6. CTCR Scholars (874)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (447)
  6. Heather Landau (436)

More People

Years
  1. 2025 (68)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (95)

More Publications

Publishers
  1. American Society of Hematology (989)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2971)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
    Journal Article

    Dispenzieri, A.; Krishnan, A.; Arendt, B.; Blackwell, B.; Wallace, P. K.; Dasari, S.; Vogl, D. T.; Efebera, Y.; Fei, M.; Geller, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Outcome of allogeneic transplantation for mature T-cell lymphomas: Impact of donor source and disease characteristics
    Journal Article

    Hamadani, M.; Ngoya, M.; Sureda, A.; Bashir, Q.; Litovich, C. A.; Finel, H.; Chen, Y.; Boumendil, A.; Zain, J.; Castagna, L.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: A noncomparative cohort analysis
    Journal Article

    Hamadani, M.; Gopal, A. K.; Pasquini, M.; Kim, S.; Qiu, X.; Ahmed, S.; Lazaryan, A.; Raj Bhatt, V.; Daly, A.; Lulla, P.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis
    Journal Article

    Dispenzieri, A.; Kastritis, E.; Wechalekar, A. D.; Schönland, S. O.; Kim, K.; Sanchorawala, V.; Landau, H. J.; Kwok, F.; Suzuki, K.; Comenzo, R. L.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Highly selective irreversible ITK inhibitor Cpi-818 reduces acute graft-versus host disease
    Meeting Abstract

    Lindner, S.; Lee, N.; Armijo, G. K.; Burgos da Silva, Marina; Herrera, P. S.; Nguyen, C. L.; Dwomoh, E. A.; Ghale, R.; Smith, M.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Post-transplant cyclophosphamide is associated with improved clinical outcomes in HLA-mismatched unrelated donor hematopoietic cell transplantation
    Meeting Abstract

    Jimenez, A. M.; Perales, M. A.; Devlin, S. M.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Beitinjaneh, A.; Brown, S.; Wang, T.; Ponce, D. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical experience in the randomized phase 3 Sierra Trial: Anti-CD45 iodine ((131)I) apamistamab [Iomab-B] conditioning enables hematopoietic cell transplantation with successful engraftment and acceptable safety in patients with active, relapsed/refractory AML not responding to targeted therapies
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Litzow, M. R.; Koshy, N. V.; Stiff, P.; Abboud, C. Sr; Tomlinson, B.; Abhyankar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Outcomes of aggressive B cell lymphoma patients with no evidence of measurable disease at the time of CD19 chimeric antigen receptor T cell therapy: The experience from the CAR T Cell Consortium
    Meeting Abstract

    Wudhikarn, K.; Tomas, A. A.; Brower, J.; Bachanova, V.; Maziarz, R. T.; McGuirk, J. P.; Nastoupil, L.; Porter, D. L.; Riedell, P. A.; Perales, M. A.
    Blood (2021)

    Fulltext@MSK | Save
  • Pharmacodynamic analysis of CAR-T cell persistence in patients with hematologic malignancies treated with NKTR-255, an IL-15 receptor agonist that enhances CD8 (+) T-cells: Preliminary results from a phase 1 study
    Meeting Abstract

    Turtle, C. J.; Budde, E.; Patel, K. K.; Perales, M. A.; Cowan, A. J.; Saeed, H.; Chavez, J. C.; Hirayama, A. V.; Kirchmeier, D. R.; Janakiram, M.; more...
    Blood (2021)

    Fulltext@MSK | Save